Antibody data
- Antibody Data
- Antigen structure
- References [5]
- Comments [0]
- Validations
- Western blot [1]
Submit
Validation data
Reference
Comment
Report error
- Product number
- 25234-1-AP - Provider product page
- Provider
- Proteintech Group
- Product name
- MYT1L antibody
- Antibody type
- Polyclonal
- Description
- MYT1L antibody (Cat. #25234-1-AP) is a rabbit polyclonal antibody that shows reactivity with human and has been validated for the following applications: WB,ELISA.
- Reactivity
- Human
- Host
- Rabbit
- Conjugate
- Unconjugated
- Isotype
- IgG
- Vial size
- 20ul, 150ul
Submitted references Asynchronous microexon splicing of LSD1 and PHF21A during neurodevelopment.
MYT1L is required for suppressing earlier neuronal development programs in the adult mouse brain.
Age-related Huntington's disease progression modeled in directly reprogrammed patient-derived striatal neurons highlights impaired autophagy.
miRNA-338-3p inhibits glioma cell proliferation and progression by targeting MYT1L.
A MYT1L syndrome mouse model recapitulates patient phenotypes and reveals altered brain development due to disrupted neuronal maturation.
Nagai M, Porter RS, Hughes E, Saunders TL, Iwase S
bioRxiv : the preprint server for biology 2024 Mar 21;
bioRxiv : the preprint server for biology 2024 Mar 21;
MYT1L is required for suppressing earlier neuronal development programs in the adult mouse brain.
Chen J, Fuhler NA, Noguchi KK, Dougherty JD
Genome research 2023 Apr;33(4):541-556
Genome research 2023 Apr;33(4):541-556
Age-related Huntington's disease progression modeled in directly reprogrammed patient-derived striatal neurons highlights impaired autophagy.
Oh YM, Lee SW, Kim WK, Chen S, Church VA, Cates K, Li T, Zhang B, Dolle RE, Dahiya S, Pak SC, Silverman GA, Perlmutter DH, Yoo AS
Nature neuroscience 2022 Nov;25(11):1420-1433
Nature neuroscience 2022 Nov;25(11):1420-1433
miRNA-338-3p inhibits glioma cell proliferation and progression by targeting MYT1L.
Yu Z, Liu Y, Li Y, Zhang J, Peng J, Gong J, Xia Y, Wang L
Brain research bulletin 2022 Feb;179:1-12
Brain research bulletin 2022 Feb;179:1-12
A MYT1L syndrome mouse model recapitulates patient phenotypes and reveals altered brain development due to disrupted neuronal maturation.
Chen J, Lambo ME, Ge X, Dearborn JT, Liu Y, McCullough KB, Swift RG, Tabachnick DR, Tian L, Noguchi K, Garbow JR, Constantino JN, Gabel HW, Hengen KB, Maloney SE, Dougherty JD
Neuron 2021 Dec 1;109(23):3775-3792.e14
Neuron 2021 Dec 1;109(23):3775-3792.e14
No comments: Submit comment
Supportive validation
- Submitted by
- Proteintech Group (provider)
- Main image
- Experimental details
- HeLa cells were subjected to SDS PAGE followed by western blot with 25234-1-AP( MYT1L Antibody) at dilution of 1:600
- Other comments
- WB